Company / Inventory
BioLife Solutions, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$30.2M
FY2025
5-year range
$27.2M / $34.9M
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#99 of 118
Health Care
What the data says
BioLife Solutions, Inc.'s inventory of $30M is lower than 84% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $2M in FY2016 to $35M in FY2022.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +21.1%.
Improved from $27M to $30M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 118This company $30.2M Sector average $1.4B
▼
-97.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.1%, indicating consistent growth.
- In FY2025, inventory increased 3.9% year-over-year.
- Ranks #99 out of 118 companies in the Health Care sector.
- Peak inventory was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.2M | +3.9% |
| FY2024 | $29.0M | +6.8% |
| FY2023 | $27.2M | -22.2% |
| FY2022 | $34.9M | +23.1% |
| FY2021 | $28.3M | +144.3% |
| FY2020 | $11.6M | +5.7% |
| FY2019 | $11.0M | +497.3% |
| FY2018 | $1.8M | -0.5% |
| FY2017 | $1.8M | +5.1% |
| FY2016 | $1.8M | -4.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026